4.7 Review

Potential Therapeutic Effect and Mechanisms of Mesenchymal Stem Cells-Extracellular Vesicles in Renal Fibrosis

Related references

Note: Only part of the references are listed.
Review Pharmacology & Pharmacy

Therapeutic and delivery strategies of phytoconstituents for renal fibrosis

Huan Xu et al.

Summary: CKD is a common disease endangering human health and life, with RF being an important intermediate link in the progression of CKD. Active phytoconstituents extracted from various plants have potential therapeutic capabilities in RF treatment and can be structurally modified or combined with other ingredients to enhance efficiency and reduce toxicity. Delivery strategies of phytoconstituents can overcome renal barriers, improve bioavailability, and targeting in RF treatment.

ADVANCED DRUG DELIVERY REVIEWS (2021)

Article Chemistry, Multidisciplinary

Mesenchymal Stem Cell-Derived Extracellular Vesicles Attenuate Mitochondrial Damage and Inflammation by Stabilizing Mitochondrial DNA

Meng Zhao et al.

Summary: The study demonstrates that MSC-EVs can alleviate mtDNA damage and inflammation after acute kidney injury, with their effects partially dependent on the TFAM signaling pathway. This suggests that MSC-EVs are promising nanotherapeutics for diseases characterized by mitochondrial damage, highlighting the essential role of TFAM in maintaining their regenerative capacity.

ACS NANO (2021)

Review Immunology

Mesenchymal stromal cells for systemic sclerosis treatment

Dominique Farge et al.

Summary: Systemic sclerosis (SSc) is a rare chronic autoimmune disease characterized by vasculopathy, dysregulation of immune responses, and progressive fibrosis. Mesenchymal stromal cells (MSC) have shown promise as a potential stem cell therapy for SSc, with studies demonstrating proangiogenic, immuno-suppressive, and anti-fibrotic properties. Preclinical studies in animal models and early clinical trials in humans have reported positive results in reducing fibrosis in SSc patients.

AUTOIMMUNITY REVIEWS (2021)

Article Cell & Tissue Engineering

Regulation of connective tissue growth factor expression by miR-133b for the treatment of renal interstitial fibrosis in aged mice with unilateral ureteral obstruction

Dan Cao et al.

Summary: miR-133b exerts targeted inhibitory effects on CTGF expression, reducing TGF-beta 1-induced EMT of HK2 cells and renal interstitial fibrosis in aged mice. Increased expression of miR-133b significantly alleviates renal interstitial fibrosis in mice with UUO.

STEM CELL RESEARCH & THERAPY (2021)

Article Genetics & Heredity

MicroRNAs are minor constituents of extracellular vesicles that are rarely delivered to target cells

Manuel T. Albanese et al.

Summary: The study found that the miRNAs carried by extracellular vesicles (EVs) do not effectively facilitate cell-to-cell communication.

PLOS GENETICS (2021)

Article Cell & Tissue Engineering

Critical considerations for the development of potency tests for therapeutic applications of mesenchymal stromal cell-derived small extracellular vesicles

Mario Gimona et al.

Summary: Mesenchymal stromal/stem cells (MSCs) have been approved for treating certain diseases through paracrine secretion of small extracellular vesicles (sEVs). Despite the potential advantages of sEV preparations over cellular MSC products, there are challenges in developing MSC-sEV drug products, including establishing quality control metrics and developing effective potency assays.

CYTOTHERAPY (2021)

Article Cell Biology

Microvesicles derived from human umbilical cord mesenchyme promote M2 macrophage polarization and ameliorate renal fibrosis following partial nephrectomy via hepatocyte growth factor

Tao Du et al.

Summary: The study shows that MSC-MVs promote M2 macrophage polarization and attenuate renal fibrosis following ischemia-PN via transferring HGF.

HUMAN CELL (2021)

Review Cell & Tissue Engineering

Mesenchymal stem cell-derived extracellular vesicles in therapy against fibrotic diseases

Yuling Huang et al.

Summary: This review summarizes the preclinical research status of MSC-EVs in treating fibrotic diseases, highlighting their potential superiority over MSCs. However, there is still a significant knowledge gap in treating fibrosis of other tissues and organs, which requires further exploration.

STEM CELL RESEARCH & THERAPY (2021)

Review Immunology

Mesenchymal Stem Cell-Derived Extracellular Vesicles: A Potential Therapeutic Strategy for Acute Kidney Injury

Jia-Kun Li et al.

Summary: AKI is a common and life-threatening disease that can progress to chronic kidney disease or end-stage renal disease if left uncontrolled. MSCs and MSC-EVs are promising cell sources for treating AKI, with lower immunogenicity and easier storage.

FRONTIERS IN IMMUNOLOGY (2021)

Review Biochemistry & Molecular Biology

Extracellular Vesicles of Mesenchymal Stem Cells: Therapeutic Properties Discovered with Extraordinary Success

Gabriella Racchetti et al.

Summary: Mesenchymal stem cells (MSCs) are known for their various properties, but their therapeutic actions come with risks and defects, leading to their replacement by extracellular vesicles (MSC-EVs), which offer comparable or even superior efficacy without the drawbacks of MSCs.

BIOMEDICINES (2021)

Article Immunology

Mesenchymal Stem Cell-Derived Extracellular Vesicles: A Novel Cell-Free Therapy

Morteza Jafarinia et al.

IMMUNOLOGICAL INVESTIGATIONS (2020)

Article Cell Biology

Mesenchymal Stem Cell Derived Extracellular Vesicles Ameliorate Kidney Injury in Aristolochic Acid Nephropathy

Sharad Kholia et al.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)

Review Biochemistry & Molecular Biology

Cellular and molecular mechanisms of kidney fibrosis

Sonja Djudjaj et al.

MOLECULAR ASPECTS OF MEDICINE (2019)

Article Cell Biology

Defining mesenchymal stromal cell (MSC)-derived small extracellular vesicles for therapeutic applications

Kenneth W. Witwer et al.

JOURNAL OF EXTRACELLULAR VESICLES (2019)

Review Cell & Tissue Engineering

Mesenchymal Stem Cells in Renal Fibrosis: The Flame of Cytotherapy

Quan Zhuang et al.

STEM CELLS INTERNATIONAL (2019)

Review Physiology

Mechanisms of Renal Fibrosis

Benjamin D. Humphreys

ANNUAL REVIEW OF PHYSIOLOGY, VOL 80 (2018)

Review Cell & Tissue Engineering

Mesenchymal Stem Cell Therapy of Pulmonary Fibrosis Improvement with Target Combination

Hong-Meng Chuang et al.

CELL TRANSPLANTATION (2018)

Review Gastroenterology & Hepatology

Mesenchymal stromal cell therapy for liver diseases

Mohammed Alfaifi et al.

JOURNAL OF HEPATOLOGY (2018)

Review Urology & Nephrology

Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases

Yufang Shi et al.

NATURE REVIEWS NEPHROLOGY (2018)

Article Medicine, Research & Experimental

Mesenchymal stem cells-microvesicle-miR-451a ameliorate early diabetic kidney injury by negative regulation of P15 and P19

Ling Zhong et al.

EXPERIMENTAL BIOLOGY AND MEDICINE (2018)

Review Cell Biology

Epithelial-mesenchymal transition in tissue repair and fibrosis

Rivka C. Stone et al.

CELL AND TISSUE RESEARCH (2016)

Article Cell Biology

Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper

Thomas Lener et al.

JOURNAL OF EXTRACELLULAR VESICLES (2015)

Article Multidisciplinary Sciences

Quantitative and stoichiometric analysis of the microRNA content of exosomes

John R. Chevillet et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)